Skip to main content
. 2017 Jan 13;8(10):16356–16366. doi: 10.18632/oncotarget.14633

Table 2. Univariate analysis of OS.

Characteristic Age (years) Cases Median Survival (months) 95% (CI) (months) P-value
< 60 19 5.0 ± 0.6 3.6–6.5 P = 0.645
> = 60 26 6.0 ± 0.5 4.9–7.2
Gender
Male 20 5.0 ± 0.7 3.5–6.8 P = 0.263
Female 25 6.0 ± 0.5 5.0–7.0
Differentiation
Poorly 28 5.0 ± 0.7 3.5–6.5 P = 0.328
Medium and high 17 8.0 ± 0.5 1.8–15.2
Treatment
Chemical treatment 25 6.0 ± 0.8 4.0–8.2 P = 0.048
None 20 4.0 ± 0.4 2.7–5.6
YAP expression
High and moderate 37 4.0 ± 0.6 3.1–5.1 P = 0.015
low and none 8 7.0 ± 0.6 5.4–8.2

Abbreviations: CI, confidence interval.

low YAP expression and chemotherapy treatment were positively correlated with the patients’ survival (p = 0.015 and p = 0.048).